参考文献/References:
[1]HansenAlgenstaedt N,Kwan MK,Algenstaedt P.Comparison between minimally invasive surgery and conventional open surgery for patients with spinal metastasis:a prospective propensity scorematched study.Spine,2017,42(10):789-797.
[2]Pennington Z,Ahmed AK,Molina CA,et al. Minimally invasive versus conventional spine surgery for vertebral metastases:a systematic review of the evidence.Ann Transl Med,2018,6(6):103.
[3]Tou S,Bergamaschi R.Laparoscopic rectal cancer resection: inferior to open or not?Colorectal Dis,2016,18(3):233.
[4]Yamaguchi T,Konishi T,Kinugasa Y,et al.Laparoscopic versus open lateral lymph node dissection for locally advanced low rectal cancer:a subgroup analysis of a large multicenter cohort study in Japan.Dis Colon Rectum,2017,60(9):954-964.
[5]周循，刘小倩，朱娜娜，等．输血与造血干细胞相关的研究进展．临床输血与检验,2019,21(3):330-333．
[6]张志永，黄宇光.术中自体血回输的临床和研究进展.中国输血杂志，2014,27(11):1093-1095．
[7]郑显良，姚中吉.回收式自体/异体输血对心脏手术患者的影响.中国输血杂志,2019,32(8):786-789．
[8]Nakanishi K,Kanda M,Kodera Y.Longlasting discussion:adverse effects of intraoperative blood loss and allogeneic transfusion on prognosis of patients with gastric cancer.World J Gastroenterol,2019,25(22):2743-2751.
[9]李栋林，梁廷波，郑树森.自体血液回输在肿瘤手术中的应用现状及进展.中国实用外科杂志，2007，27（2）：160-162.
[10]周炜鑫,许凯强.肿瘤患者回输辐照自体血的研究.检验医学与临床,2015,24(12):3769-3771.
[11]Trudeau JD,Waters T,Chipperfield K.Should intraoperative cellsalvaged blood be used in patients with suspected or known malignancy.Can J Anaesth,2012,59(11):1058-1070.
[12]Wang T,Luo L,Huang H,et al.Perioperative blood transfusion is associated with worse clinical outcomes in resected lung cancer.Ann Thorac Surg,2014,97(5):1827-1837.
[13]赵赟博,黄莹莹.恶性肿瘤相关性贫血临床治疗进展.中国疼痛医学杂志,2012,18(10):593-597.
[14]Ludwig H,Van Belle S,BarrettLee P,et al.The European Cancer Anemia Survey (ECAS):a large multinational prospective survey defining the prevalence incidence and treatment of anemia in cancer patients.Eur J Cancer,2004,40(15):2293-2306.
[15]Kumar N,Zaw AS,Khoo BL,et al.Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells.Eur Spine J,2016,25(12):4008-4015.
[16]Catling S,Williams S,Freites O,et al.Use of a leucocyte filter to remove tumour cells from intraoperative cell salvage blood.Anaesthesia,2008,63(12):1332-1338.
[17]Kumar N,Ahmed Q,Lee VK,et al.Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery?Eur Spine J,2016,25(12):3997-4007.
[18]Karczewski DM,Lema MJ,Glaves D.The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery.Anesth Analg,1994,78(6):1131-1135.
[19]Gray CL,Amling CL,Polston GR,et al.Intraoperative cell salvage in radical retropubic prostatectomy.Urology,2001,58(5):740-745.
[20]Nieder AM,Manoharan M,Yang Y,et al.Intraoperative cell salvage during radical cystectomy does not affect longterm survival.Urology,2007,69(5):881-884.
[21]Lyon TD,Ferroni MC,Turner RM 2nd,et al.Short term outcomes of intraoperative cell saver transfusion during open partial nephrectomy.Urology,2015,86(6):1153-1158.
[22]Han S,Kim G,Ko JS,et al.Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma.Ann Surg,2016,264(2):339-343.
[23]Araujo RL,Pantanali CA,Haddad L,et al.Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?World J Gastrointest Surg,2016,8(2):161-168.
[24]Bower MR,Ellis SF,Scoggins CR,et al.Phase Ⅱ comparison study of intraoperative autotransfusion for major oncologic procedures.Ann Surg Oncol,2011,18(1):166-173.
[25]Kang R,Seath BE,Huang V,et al.Impact of autologous blood transfusion on survival and recurrence among patients undergoing partial hepatectomy for colorectal cancer liver metastases.J Am Coll Surg,2019,228(6):902-908.
[26]Engle DB,Connor JP,Morris PC,et al.Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer:longterm followup of a prospective trial.Arch Gynecol Obstet,2012,286(3):717-721.
[27]Wu WW,Zhang WY,Zhang WH,et al.Survival analysis of intraoperative blood salvage for patients with malignancy disease.Medicine (Baltimore),2019,98(27):e16040.
[28]Marraccini C,Merolle L,Berni P,et al.Safety of leucodepleted salvaged blood in oncological surgery:an in vitro model.Vox Sanguinis,2017,112(8): 803-805.
[29]Naresh K,Nivetha R,Joel YHT,et al.Current status of the use of salvaged blood in metastatic spine tumour surgery.Neurospine,2018,15(3):206-215.